Home/Pipeline/Next-Gen Closed-Loop DBS System

Next-Gen Closed-Loop DBS System

Parkinson's Disease, Essential Tremor, Dystonia, Drug-Resistant Epilepsy

Pre-clinicalActive

Key Facts

Indication
Parkinson's Disease, Essential Tremor, Dystonia, Drug-Resistant Epilepsy
Phase
Pre-clinical
Status
Active
Company

About Torpedo Therapeutics

Torpedo Therapeutics is a private, pre-revenue biotech/neurotech company founded in 2020 and based in San Diego. The company is developing a novel DBS platform that integrates microfabricated electrode leads for high-precision stimulation, closed-loop sensing capabilities, and a machine learning-driven data analysis platform for automated therapy adjustment. This approach targets the significant side effects and inefficiencies of current 'always-on' DBS systems. While still in early development, the technology has the potential to improve efficacy, reduce side effects, and decrease the clinical burden for patients with severe neurological disorders.

View full company profile

Therapeutic Areas